FOS and obesity due to melanocortin 4 receptor deficiency: Further analysis of human tumor tissues, incorporating clinical data, revealed that patients with relatively high FOS hepatic expression also had higher body weight (n = 344) or higher body mass index (BMI) (n = 335, 158/335 BMI > 25 kg m−2), consistent with increased FOS in obesity.